Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies

The effect of itopride hydrochloride or ranitidine on the health-related quality of life (HRQoL) of functional dyspepsia is not well known. Our aim was to assess the HRQoL before and after administration of itopride hydrochloride or ranitidine in patients with functional dyspepsia. A total of 18 fun...

Full description

Saved in:
Bibliographic Details
Published inHepato-gastroenterology Vol. 54; no. 78; p. 1878
Main Authors Chiba, Toshimi, Tokunaga, Yumi, Ikeda, Keisei, Takagi, Ryo, Chishima, Raita, Terui, Torahiko, Kudara, Norihiko, Endo, Masaki, Inomata, Masaaki, Orii, Seishi, Suzuki, Kazuyuki
Format Journal Article
LanguageEnglish
Published Greece 01.09.2007
Subjects
Adult
Aged
Anti-Ulcer Agents - administration & dosage
Benzamides - administration & dosage
Benzyl Compounds - administration & dosage
Dyspepsia - drug therapy
Female
Gastroesophageal Reflux - drug therapy
Humans
Kinetics
Male
Middle Aged
Quality of Life
Ranitidine - administration & dosage
Surveys and Questionnaires
Treatment Outcome
Online AccessGet more information

Cover

More Information
Summary:The effect of itopride hydrochloride or ranitidine on the health-related quality of life (HRQoL) of functional dyspepsia is not well known. Our aim was to assess the HRQoL before and after administration of itopride hydrochloride or ranitidine in patients with functional dyspepsia. A total of 18 functional dyspepsia patients (12 women, 6 men; mean age 52.5 y.o.) were enrolled. We determined the HRQoL using two different inquiry systems: the 36 item short form of the Medical Outcome Study Questionnaire (SF-36) and the Gastrointestinal Symptom Rating Scale (GSRS). The HRQoL was determined before administration of drug, and two, four, and eight weeks after administration of drug. After administration of itopride hydrochloride, the SF-36 mental health scale and GSRS indigestion syndrome score and constipation syndrome score were significantly improved compared to before administration (p < 0.05). After the administration of ranitidine, the GSRS reflux syndrome score was significantly improved compared to before administration (p < 0.05). Itopride hydrochloride would be useful for the treatment of dysmotility-type functional dyspepsia, whereas ranitidine would be beneficial for ulcer-type functional dyspepsia.
ISSN:0172-6390